NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹21 Cr | ₹25 Cr | ₹-69 Cr | ₹-136 Cr | ₹38 Cr |
What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹21 Cr |
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹-69 Cr |
| Mar2023 | ₹-136 Cr |
| Mar2022 | ₹38 Cr |
How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹21 Cr | -15.97 | |
| Mar2025 | ₹25 Cr | Positive | |
| Mar2024 | ₹-69 Cr | Negative | |
| Mar2023 | ₹-136 Cr | Negative | |
| Mar2022 | ₹38 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹27,462.5 Cr | 6.2% | 8.9% | 22.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 6.2% |
8.9% |
22.9% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses